No results for ‘’
Anthem Biosciences Ltd
₹769.10
(1.46%)
Tue, 26 May 2026, 06:27 pm
Health Technology
Biotechnology
24.5KAnthem Biosciences Price to Cash Flow Ratio
| Particulars | 2021 | 2022 | 2023 |
|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 |
| Price to book ratio | 0 | 0 | 0 |
| Price to sales ratio | 0 | 0 | 0 |
| Price to cash flow ratio | 0 | 0 | 0 |
| Enterprise value | 0 | 0 | 0 |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 |
| Debt to equity ratio | 0.03 | 0.07 | 0.12 |
| Return on equity % | 0 | 24.89 | 20.04 |
Anthem Biosciences Ltd Price to Cash Flow Ratio
The Anthem Biosciences Ltd Price to Cash Flow Ratio is a key financial metric used by investors to evaluate Anthem Biosciences Ltd's valuation, profitability, and overall financial performance. Tracking the Anthem Biosciences Ltd Price to Cash Flow Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Anthem Biosciences Ltd (NSE: ANTHEM, BSE: 544449) is currently trading at ₹769.10, with a market capitalization of ₹438.28B. As a leading company in the Health technology sector and Biotechnology industry, monitoring the Anthem Biosciences Ltd Price to Cash Flow Ratio is essential for fundamental analysis.
Anthem Biosciences Ltd Price to Cash Flow Ratio Current Value
The current Anthem Biosciences Ltd Price to Cash Flow Ratio stands at 0.
The Anthem Biosciences Ltd Price to Cash Flow Ratio remains stable, indicating consistent financial performance.
Anthem Biosciences Ltd Price to Cash Flow Ratio Historical Trend
The Anthem Biosciences Ltd Price to Cash Flow Ratio has shown the following historical trend:
- 2023: 0
- 2022: 0
- 2021: 0
The decline in Anthem Biosciences Ltd Price to Cash Flow Ratio indicates improving financial efficiency or better earnings growth.
What Anthem Biosciences Ltd Price to Cash Flow Ratio Indicates for Investors
The Anthem Biosciences Ltd Price to Cash Flow Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/CF ratio indicates how much investors pay for company cash flow.
Anthem Biosciences Ltd Price to Cash Flow Ratio Analysis Summary
The Anthem Biosciences Ltd Price to Cash Flow Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Anthem Biosciences Ltd Price to Cash Flow Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Anthem Biosciences Ltd Price to Cash Flow Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.